Market Tracker

01/20 4:36am ET

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

2.67
Delayed Data
As of Jan 19
 +0.03 / +1.14%
Today’s Change
1.65
Today|||52-Week Range
6.37
+6.80%
Year-to-Date
No recent news for Imprimis Pharmaceuticals Inc.

Today’s Trading

Previous close2.64
Today’s open2.58
Day’s range2.55 - 2.72
Volume65,960
Average volume (3 months)93,218
Market cap$35.0M
Dividend yield--
Data as of 01/19/2017

Growth & Valuation

Earnings growth (last year)-49.55%
Earnings growth (this year)+20.48%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+485.21%
P/E ratioNM
Price/Sales6.83
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RPRXRepros Therapeutics ...-0.03-2.16%
FCSCFibrocell Science In...-0.02-2.73%
NVLSNivalis Therapeutics...-0.03-1.34%
PRPHProPhase Labs Inc-0.01-0.50%
Data as of 01/19/2017

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$9.7M
Annual profit (last year)-$15.9M
Net profit margin-163.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
Senior Operations Director
Joe Bitterman
Corporate headquarters
San Diego, California

Forecasts